Holder AL - Search Results

1

ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.

Davis PD, Dougherty GJ, Blakey DC, Galbraith SM, Tozer GM, Holder AL, Naylor MA, Nolan J, Stratford MR, Chaplin DJ, Hill SA. Davis PD, et al. Among authors: holder al. Cancer Res. 2002 Dec 15;62(24):7247-53. Cancer Res. 2002. PMID: 12499266

2

Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide.

Parkins CS, Holder AL, Hill SA, Chaplin DJ, Tozer GM. Parkins CS, et al. Among authors: holder al. Br J Cancer. 2000 Sep;83(6):811-6. doi: 10.1054/bjoc.2000.1361. Br J Cancer. 2000. PMID: 10952787 Free PMC article.

3

Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy.

Cemazar M, Parkins CS, Holder AL, Chaplin DJ, Tozer GM, Sersa G. Cemazar M, et al. Among authors: holder al. Br J Cancer. 2001 Feb;84(4):565-70. doi: 10.1054/bjoc.2000.1625. Br J Cancer. 2001. PMID: 11207055 Free PMC article.

4

Involvement of oxygen free radicals in ischaemia-reperfusion injury to murine tumours: role of nitric oxide.

Parkins CS, Holder AL, Dennis MF, Stratford MR, Chaplin DJ. Parkins CS, et al. Among authors: holder al. Free Radic Res. 1998 Mar;28(3):271-81. doi: 10.3109/10715769809069279. Free Radic Res. 1998. PMID: 9688213

5

Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice.

Cemazar M, Parkins CS, Holder AL, Kranjc S, Chaplin DJ, Sersa G. Cemazar M, et al. Among authors: holder al. Anticancer Res. 2001 Mar-Apr;21(2A):1151-6. Anticancer Res. 2001. PMID: 11396155

6

Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).

Dorey EL, Outram SV, Holder A, Rohatiner AZ, Cotter FE, Deane M, Stansfeld AG, Lister TA, Horton MA. Dorey EL, et al. Br J Cancer. 1989 May;59(5):772-4. doi: 10.1038/bjc.1989.161. Br J Cancer. 1989. PMID: 2472166 Free PMC article. No abstract available.

7

Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines.

Palmero I, Holder A, Sinclair AJ, Dickson C, Peters G. Palmero I, et al. Oncogene. 1993 Apr;8(4):1049-54. Oncogene. 1993. PMID: 8455931

8

CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G. Bates S, et al. Oncogene. 1994 Jan;9(1):71-9. Oncogene. 1994. PMID: 8302605

9

Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene.

Sinclair AJ, Palmero I, Holder A, Peters G, Farrell PJ. Sinclair AJ, et al. J Virol. 1995 Feb;69(2):1292-5. doi: 10.1128/JVI.69.2.1292-1295.1995. J Virol. 1995. PMID: 7529333 Free PMC article.

10

Sequential expression of three known protective genes in cardiac biopsies after transplantation.

Souza AI, Felkin LE, McCormack AM, Holder A, Barton PJ, Banner NR, Rose ML. Souza AI, et al. Transplantation. 2005 Mar 15;79(5):584-90. doi: 10.1097/01.tp.0000153154.37616.94. Transplantation. 2005. PMID: 15753848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters